Canada markets open in 1 hour 3 minutes

Purple Biotech Ltd (PPBT)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.5127+0.0227 (+4.63%)
At close: 04:00PM EDT
0.5400 +0.02 (+3.65%)
Pre-Market: 08:27AM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 13.86M
Enterprise Value -1.20M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.39
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 0.06

Trading Information

Stock Price History

Beta (5Y Monthly) 0.57
52-Week Change 3-73.83%
S&P500 52-Week Change 322.64%
52 Week High 32.0800
52 Week Low 30.3020
50-Day Moving Average 30.6798
200-Day Moving Average 30.9599

Share Statistics

Avg Vol (3 month) 3120.73k
Avg Vol (10 day) 3227.31k
Shares Outstanding 525.99M
Implied Shares Outstanding 628.01M
Float 8235.63M
% Held by Insiders 14.05%
% Held by Institutions 19.40%
Shares Short (Apr 15, 2024) 4222.22k
Short Ratio (Apr 15, 2024) 42.89
Short % of Float (Apr 15, 2024) 4N/A
Short % of Shares Outstanding (Apr 15, 2024) 40.90%
Shares Short (prior month Mar 15, 2024) 4223k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Aug 21, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Aug 21, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-28.14%
Return on Equity (ttm)-49.09%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -22.23M
Net Income Avi to Common (ttm)-19.88M
Diluted EPS (ttm)-0.9000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)15.41M
Total Cash Per Share (mrq)0.06
Total Debt (mrq)351k
Total Debt/Equity (mrq)1.02%
Current Ratio (mrq)2.20
Book Value Per Share (mrq)0.14

Cash Flow Statement

Operating Cash Flow (ttm)-19.93M
Levered Free Cash Flow (ttm)-10.95M